CYEX LLC – Trademark Portfolio
Entity Type: 16
CYEX LLC holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 15 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 4 Nice Classification classes. Currently, 12 trademarks are registered and 2 are pending. Notable registered marks include CYEX, MINOR DEFENSE, MEDICAL SHIELD, FINANCIAL SHIELD, and IDENTITY DEFENSE. The owner is based in BOSTON, MA.
250 NORTHERN AVENUE
3RD FLOOR
BOSTON, MA 02210
Showing of trademarks Trademarks
Trademark Classifications
CYEX LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CYEX LLC have?
CYEX LLC has 16 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 pending, 2 abandoned.
What trademark classes does CYEX LLC file in?
CYEX LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CYEX LLC's most well-known trademarks?
CYEX LLC's registered trademark portfolio includes well-known marks such as CYEX, MINOR DEFENSE, MEDICAL SHIELD, FINANCIAL SHIELD, and IDENTITY DEFENSE. These are among 12 currently registered trademarks in the portfolio.
What is CYEX LLC's trademark registration success rate?
CYEX LLC has a 86% trademark registration rate, with 12 out of 14 resolved applications resulting in successful registration. Currently, 2 applications are pending review.